| Basics |
|
Sana Biotechnology, Inc.
|
| IPO Date: |
February 1, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$1.47B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.35 | 4.26%
|
| Avg Daily Range (30 D): |
$0.20 | 4.95%
|
| Avg Daily Range (90 D): |
$0.16 | 4.35%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.8M |
| Avg Daily Volume (30 D): |
5.01M |
| Avg Daily Volume (90 D): |
5.12M |
| Trade Size |
| Avg Trade Size (Sh.): |
139 |
| Avg Trade Size (Sh.) (30 D): |
204 |
| Avg Trade Size (Sh.) (90 D): |
217 |
| Institutional Trades |
| Total Inst.Trades: |
1,351 |
| Avg Inst. Trade: |
$1.86M |
| Avg Inst. Trade (30 D): |
$1.6M |
| Avg Inst. Trade (90 D): |
$1.35M |
| Avg Inst. Trade Volume: |
.25M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2M |
| Avg Closing Trade (30 D): |
$1.85M |
| Avg Closing Trade (90 D): |
$1.47M |
| Avg Closing Volume: |
264.79K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$-1.06
|
$-.39
|
$-.21
|
|
Diluted EPS
|
$-1.06
|
$-.39
|
$-.21
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -252.18M
|
$ -93.8M
|
$ -49.39M
|
|
Operating Income / Loss
|
$ -258.23M
|
$ -94.98M
|
$ -50.63M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -63.32M
|
$ -24.86M
|
$ -31.07M
|
|
PE Ratio
|
|
|
|
|
|
|